An Objective Measure of Stress at Scale

Using nothing more than the smartphone camera, Mobio Interactive's proprietary technology accurately and objectively measures stress in under 30 seconds.

We start with a colour scan of the face and pass the time series data from six different wavelengths of light into an algorithm that outputs heart rate (HR) and heart rate variability (HRV). This is possible because as your heart beats, your facial arteries dilate and contract in synchrony.
We next send these HR and HRV data to a deep neural network that has been trained on thousands of individuals from all over the world, and this network then predicts - with remarkable accuracy - the level of stress that the data represent. Specifically, the AI is measuring the autonomic nervous system, which is what governs your "fight or flight" versus "rest and digest" modes.
In addition, our app Am Mindfulness contains embedded tools that capture self-reported information, including a "stress slider" and "mood board". These in-app biomarkers have been benchmarked against medical questionnaires and are found to correlate with high significance.​

Clinical Studies

Mobio Interactive rigorously interrogates the efficacy of our digital therapeutics.

Am Mindfulness is the first and only resilience app proven to outperform placebo.

Stress Resilience
In a landmark study, researchers found that MI's DTx produced "significant improvement" in stress resilience amongst university students self-reporting issues with anxiety, when compared to placebo.

Attentional Control
In landmark study, researchers found that MI's DTx produced "long-term benefits for attentional control," compared to placebo, indicating that MI's app Am Mindfulness can enhance focus in university students.
​

Psycho-oncology
In a clinical trial with urban and rural cancer survivors, Am Mindfulness provides stress reductions "similar in effect sizes of in-person programs," indicating medical-grade stress relief is now accessible to cancer patients regardless of their location.

Fear of Cancer Recurrence
In a clinical trial with cancer patients, researchers are investigating the potential for Am Mindfulness to reduce the "fear of cancer recurrence," something which is often a very serious burden on cancer survivors and their loved ones.

Physical Endurance
Researchers examined the effect of mental training with Am Mindfulness versus a control app on the total physical endurance of amature athletes.

​

Mental Response to HIE
Researchers examined the mental response to HIE (High Intensity Exercise) in amature athletes who trained with Am Mindfulness versus a control app, and have found some intriguing results important for exercise paradigm adherence.

Pain
Researchers are examining the potential for reducing the chronic pain experienced by cancer patients through the use of a VR product that Mobio Interactive has under development.

Quality of Life
Researchers are examining the potential for Am Mindfulness to improve psychological outcomes, as well as overall quality of life in patients with kidney cancer.

Much of our ongoing research in patient populations is currently confidential, but we're committed to disseminating the results as soon as possible, for the benefit of patients as well as the entire DTx industry around the world.

Interested in conducting a trial? Let us know​.
Toronto - Zurich - Shanghai - Singapore
​© 2020 Mobio Interactive PTE LTD